News

SYLKE® Awarded Breakthrough Technology Designation with Premier, Inc.

SYLKE® Awarded Breakthrough Technology Designation with Premier, Inc.

July 15, 2025 The designation provides Premier member hospitals and health systems with access to SYLKE® Adhesive Wound Closure through the nation's largest group purchasing organization. SYLKE® Adhesive Wound Closure has been awarded a Breakthrough Technology Designation with Premier, Inc.,...

Read moreabout SYLKE® Awarded Breakthrough Technology Designation with Premier, Inc.

SYLKE® Named an Allure 2024 Best of Beauty Breakthrough

SYLKE® Named an Allure 2024 Best of Beauty Breakthrough

Allure recognized SYLKE® Adhesive Wound Closure in its annual Best of Beauty Awards, selecting it for the Breakthrough designation. Allure, the Condé Nast beauty publication, named SYLKE® Adhesive Wound Closure a 2024 Best of Beauty Breakthrough. The Breakthrough designation is...

Read moreabout SYLKE® Named an Allure 2024 Best of Beauty Breakthrough

SYLKE® Receives the 2025 AAHKS Industry Innovation Award

SYLKE® Receives the 2025 AAHKS Industry Innovation Award

October 24, 2025 SYLKE® Adhesive Wound Closure was named a recipient of the Industry Innovation Award at the 2025 American Association of Hip and Knee Surgeons Annual Meeting. At the 2025 AAHKS Annual Meeting in Dallas, Texas, Sylke, Inc. was...

Read moreabout SYLKE® Receives the 2025 AAHKS Industry Innovation Award

SYLKE® launches Global Relief: Charitable Use Program

SYLKE® launches Global Relief: Charitable Use Program

Our charitable use program that partners with nonprofits and frontline healthcare teams to deliver SYLKE® Adhesive Wound Closure dressings where they’re needed most.

Read moreabout SYLKE® launches Global Relief: Charitable Use Program

$10.03 Million Series A

$10.03 Million Series A

In March 2025, SYLKE® raised a $10.03 million Series A at a $150 million pre-money valuation.

Read moreabout $10.03 Million Series A

$5.50 Million Series Seed

$5.50 Million Series Seed

In August 2024, SYLKE® raised a $5.5 million Series Seed at a $50 million pre-money valuation.

Read moreabout $5.50 Million Series Seed